PRPO · XBRL financial data

Precipio financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PRPO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	6,092	8,849	9,412	15,197	18,532	24,049
Revenue from contracts with customers	7,431	8,697	9,820	15,415	18,576	24,246
Cost of goods and services sold	4,942	6,457	6,902	9,179	10,973	13,343
Gross profit	1,150	2,392	2,510	6,018	7,559	10,706
Research and development	1,200	1,300	1,700	1,700	1,300	1,600
Selling, general and administrative	10,296	—	—	—	—	—
Total operating expenses	10,296	12,005	15,307	13,638	11,775	11,908
Operating income (loss)	(9,146)	(9,613)	(12,797)	(7,620)	(4,216)	(1,202)
Other income (expense)	—	—	—	—	(74)	839
Income tax expense (benefit)	0	0	0	0	0	0
Net income (loss)	—	—	—	—	(4,290)	(363)
Earnings per share, basic‡ USD per share	(17.00)	(8.00)	(10.80)	(4.51)	(2.93)	(0.23)
Earnings per share, diluted‡ USD per share	(17.00)	(8.00)	(10.80)	(4.51)	(2.93)	(0.23)
Weighted average shares, basic‡ thousands of shares	824	1,055	1,138	1,298	1,466	1,605
Weighted average shares, diluted‡ thousands of shares	824	1,055	1,138	1,298	1,466	1,605

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (September 2023); filings made before it reported them unadjusted.

Fiscal years (PRPO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	2,656	11,668	3,445	1,502	1,389	2,651
Accounts receivable	874	697	1,036	1,301	799	1,984
Inventory	350	564	708	384	724	935
Total current assets	4,204	13,478	5,710	3,682	3,451	6,039
Property and equipment, net	452	836	877	739	719	729
Right-of-use asset	335	858	763	612	395	2,565
Total assets	20,713	30,439	21,504	18,101	16,996	21,317
Accounts payable	1,693	1,863	2,042	622	618	1,131
Accrued liabilities	2,036	1,918	1,584	1,824	2,799	1,690
Current portion of long-term debt	648	26	255	235	297	30
Total current liabilities	4,656	4,213	4,361	3,141	4,271	3,752
Long-term debt	362	160	134	106	77	47
Lease liability, non-current	92	697	574	407	206	2,206
Total liabilities	6,551	5,835	5,137	3,672	4,902	6,756
Accumulated deficit	(71,564)	(80,094)	(92,297)	(98,150)	(102,440)	(102,803)
Total stockholders' equity	14,135	24,564	16,302	14,429	—	—
Total liabilities and equity	20,713	30,439	21,504	18,101	16,996	21,317
Common shares outstanding (cover page)‡ thousands of shares	907	1,135	1,168	1,430	1,504	1,784

‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (September 2023); filings made before it reported them unadjusted.

Fiscal years (PRPO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	—	—	—	—	(4,290)	(363)
Stock-based compensation	703	1,879	3,801	1,558	1,491	1,209
Depreciation and amortization	1,093	1,131	1,219	1,225	1,199	1,245
Net cash from operating activities	(7,434)	(6,577)	(7,721)	(3,559)	439	685
Purchases of property and equipment	151	682	277	126	223	326
Net cash from investing activities	(96)	(682)	(277)	(126)	(223)	(326)
Proceeds from issuing common stock	8,929	16,207	129	2,245	78	—
Proceeds from long-term debt	787	—	—	—	250	—
Net cash from financing activities	9,338	16,271	(225)	1,742	(329)	903
Net change in cash	1,808	9,012	(8,223)	(1,943)	(113)	1,262

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Precipio	3,075	7,021	660*	1.8M	—	Q2 FY26 10-QJun 30, 2026
Focus Universal	1,600	675	(741)*	702,745	2.2 quarters	Q2 FY26 10-QJun 30, 2026
Harvard Bioscience	6,503	22,727	325*	4.6M	—	Q2 FY26 10-QJun 30, 2026
Bionano Genomics	3,730	8,171	(4,670)*	11.8M	2.1 quarters	Q2 FY26 10-QJun 30, 2026
MultiSensor AI Holdings	21,005	1,695	(2,392)*	2.2M	8.8 quarters	Q2 FY26 10-QJun 30, 2026
Optex Systems Holdings	6,175	9,729	2,323*	7.0M	—	Q3 FY26 10-QJun 28, 2026
Data I/O	10,843	5,149	(2,939)*	10.4M	3.7 quarters	Q2 FY26 10-QJun 30, 2026
ClearSign Technologies	9,889	not reported	(1,236)*	6.8M	8.0 quarters	Q2 FY26 10-QJun 30, 2026
Sypris Solutions	not reported	30,341	1,863*	23.0M	—	Q2 FY26 10-QJul 5, 2026

Not investment advice. Not affiliated with the U.S. SEC.